Evidence map›Paper›PMID 38051451›Full record

ArticleVeterinary research communications2024

The effect of enterocin A/P dipeptide on growth performance, glutathione-peroxidase activity, IgA secretion and jejunal morphology in rabbits after experimental methicillin-resistant Staphylococcus epidermidis P3Tr2a Infection.

Monika Pogány Simonová, Ľubica Chrastinová, Jana Ščerbová, Valentína Focková, Iveta Plachá, Katarína Tokarčíková, Rudolf Žitňan, Andrea Lauková

Erratum issuedOpen access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Veterinary research communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Microorganisms · 2026
    Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Monika Pogány SimonováCentre of Biosciences of the Slovak Academy of Sciences, Institute of Animal Physiology, Šoltésovej 4-6, Košice, 04001, Slovakia. simonova@saske.sk.ORCID https://orcid.org/0000-0002-0377-4672
Ľubica ChrastinováDepartment of Animal Nutrition, National Agricultural and Food Centre, Hlohovecká 2, Nitra-Lužianky, 95141, Slovakia.
Jana ŠčerbováCentre of Biosciences of the Slovak Academy of Sciences, Institute of Animal Physiology, Šoltésovej 4-6, Košice, 04001, Slovakia.ORCID https://orcid.org/0000-0002-8704-3657
Valentína FockováCentre of Biosciences of the Slovak Academy of Sciences, Institute of Animal Physiology, Šoltésovej 4-6, Košice, 04001, Slovakia.ORCID https://orcid.org/0000-0002-9113-3540
Iveta PlacháCentre of Biosciences of the Slovak Academy of Sciences, Institute of Animal Physiology, Šoltésovej 4-6, Košice, 04001, Slovakia.ORCID https://orcid.org/0000-0002-8724-0159
Katarína TokarčíkováCentre of Biosciences of the Slovak Academy of Sciences, Institute of Animal Physiology, Šoltésovej 4-6, Košice, 04001, Slovakia.ORCID https://orcid.org/0000-0002-9117-7869
Rudolf ŽitňanDepartment of Animal Nutrition, National Agricultural and Food Centre, Hlohovecká 2, Nitra-Lužianky, 95141, Slovakia.
Andrea LaukováCentre of Biosciences of the Slovak Academy of Sciences, Institute of Animal Physiology, Šoltésovej 4-6, Košice, 04001, Slovakia.ORCID https://orcid.org/0000-0001-7413-3816
Slovak Academy of Sciences · SKNational Agricultural and Food Centre · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing frequency of methicillin-resistant (MR) staphylococci in humans and animals need special attention for their difficult treatment and zoonotic character, therefore novel antimicrobial compounds on a natural base against antibiotic-resistant bacteria are requested. Currently, bacteriocins/enterocins present a new promising way to overcome this problem, both in prevention and treatment. Therefore, the preventive and medicinal effect of dipeptide enterocin EntA/P was evaluated against MR Staphylococcus epidermidis SEP3/Tr2a strain in a rabbit model, testing their influence on growth performance, glutathione-peroxidase (GPx) enzyme activity, phagocytic activity (PA), secretory (s)IgA, and jejunal morphometry (JM). Eighty-eight rabbits (aged 35 days, meat line M91, both sexes) were divided into experimental groups S (SEP3/Tr2a strain; 1.0 × 10

Indexed as

BacteriocinsMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnimalsAnti-Bacterial AgentsFemaleGlutathioneHumansImmunoglobulin AMaleMethicillin ResistancePeroxidasesRabbitsStaphylococcus epidermidisAnti-Bacterial AgentsBacteriocinsenterocin AGlutathioneImmunoglobulin APeroxidasesEnterocinImmunityJejunal morphometryMethicillin-resistant StaphylococcusRabbits

Identifiers

PMID38051451
PMCPMC10810977
OpenAlexW4389347087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.